Skip to main content
. 2021 Dec 6;268:110–115. doi: 10.1016/j.ejogrb.2021.12.001

Table 1.

Maternal characteristics and obstetrical history of favipiravir exposed women (n = 29).

Number (%)or Median (min/max)
Age 29 (20–39)
≤35 years 24 (82.7%)
>35 years 5 (6.8%)
Smoking
No 22 (75.9%)
≤ 5 cig/day 4 (13.8%)
> 5 cig/day 3 (10.3%)
Alcohol
No 27 (93.1%)
≤1 drink/day 2 (6.9%)
> 1 drink/day 0 (0.0%)
Chronic disease
No 22 (75.9%)
Yes 7 (24.1%)
Epilepsy 2 (28.5%)
Hypothyroidism 2 (28.5%)
Hyperthyroidism 1 (14.3%)
Allergic rhinitis 1(14.3%)
Sjögren syndrome 1(14.3%)
Asthma 1 (14.3%)
Consanguineous marriage
No 28 (96.6%)
Yes 1 (3.4%)
Previous pregnancies
0 7 (24.1%)
1 11 (37.9%)
2 8 (27.6%)
3 3 (10.4%)
Previous parities
0 10 (34.5%)
1 10 (34.5%)
2 8 (27.5%)
3 1 (3.5%)
Previous miscarriages
0 23 (79.3%)
1 5 (17.3%)
2 1 (3.4%)
Previous children with birth defect
0 28 (96.6%)
1 1 (3.4%)
Gestational week at first contact CPTU 8 (4–16)